On January 9th, HSBC Holdings (00005) spent approximately HK$35.61 million to repurchase 468,800 shares in Hong Kong.
HSBC Holdings (00005) announced that it will repurchase approximately 10,780,500 in the UK on January 9, 2025.
HSBC Holdings (00005) announced that on January 9, 2025, it will spend approximately 10.78 million to repurchase around 135.25 million shares in the UK, and approximately HK$35.6123 million to repurchase about 46.88 million shares in Hong Kong.
Related Articles
China's first domestically developed original Bcl-2 inhibitor lisaftoclax is included in the new version of the National Reimbursement Drug List, as ASCENTAGE (06855) advances its dual-engine layout in parallel with global development.
Strong earnings growth supports the valuation floor, leaving room for a valuation recovery in undervalued Shenzhen Hans CNC Technology (03200)
Two new drugs enter medical insurance for the first time, one contract renewed, EVEREST MED (01952) accelerates its multi-product commercialization system.
China's first domestically developed original Bcl-2 inhibitor lisaftoclax is included in the new version of the National Reimbursement Drug List, as ASCENTAGE (06855) advances its dual-engine layout in parallel with global development.
Strong earnings growth supports the valuation floor, leaving room for a valuation recovery in undervalued Shenzhen Hans CNC Technology (03200)
Two new drugs enter medical insurance for the first time, one contract renewed, EVEREST MED (01952) accelerates its multi-product commercialization system.
